Image

Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study compares measurements of body composition to outcomes of breast reconstruction.

Description

PRIMARY OBJECTIVES:

1\. Determine feasibility of collecting measurements of body composition.

SECONDARY OBJECTIVES:

  1. Define the differences in body composition between participants undergoing breast reconstruction who develop complications and those who do not.
  2. To determine the implications of different measures of body composition on outcomes of breast reconstruction.
  3. Compare utility of body composition measurements versus other anthropometric assessments on assessing risk of complications following breast surgery.

OUTLINE: This is a observational study. Participants are assigned to 1 of 2 cohorts and will be follow-up for up to 2 years.

Eligibility

Inclusion Criteria:

  1. Patients must have histologically confirmed breast malignancy or increased risk of developing a breast malignancy.
  2. Age ≥ 18 years.
  3. Scheduled to undergo mastectomy with immediate breast reconstruction using a permanent implant, tissue expander, or autologous tissue (e.g. Deep Inferior Epigastric Perforator (DIEP) flap, muscle-sparing Transverse Rectus Abdominis Myocutaneous (msTRAM) flap, Profunda Artery Perforator (PAP) flap).
  4. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

  1. Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study.
  2. Pregnant or breastfeeding.
  3. Patients assigned male at birth.
  4. Non-cisgender women.
  5. Patients with implanted electronic medical devices (e.g. pacemaker, defibrillator).
  6. Patients with prosthetic limbs.

Study details
    Breast Carcinoma
    Breast Cancer

NCT07546331

University of California, San Francisco

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.